AGP Limited: Financial Results for the Quarter Ended September 30, 2026

AGPAGP LimitedAGP · PharmaceuticalsFinancial resultFiled Pakistan time

Summary

AGP Limited reported a decline in revenue to Rs 17.98 billion and net profit to Rs 2.59 billion for the nine months ended September 2026, indicating a challenging period with reduced profitability.

Read the original filing

Figures in the filing

ItemThis periodPeriod beforeChange
RevenuePKR 17.98 billionPKR 20.34 billion-11.6%
Net ProfitPKR 2.59 billionPKR 2.85 billion-9.3%
Gross ProfitPKR 11.02 billionPKR 12.09 billion-9.0%
Earnings Per Share (EPS)PKR 8.29PKR 8.92-7.1%
Cash and Cash EquivalentsPKR -6.25 billionPKR -1.76 billion—

Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).

What the filing says

  • Revenue decreased by 11.63% to Rs 17.98 billion compared to Rs 20.34 billion in the prior period.
  • Net profit declined by 9.35% to Rs 2.59 billion from Rs 2.85 billion in the previous year.
  • Cash and cash equivalents showed a significant decrease, ending at a negative Rs 6.25 billion, indicating liquidity challenges.

AGP Limited (AGP) on Nafa

Last price Rs 155.97 · Pharmaceuticals · You can own AGP shares from your phone.

More AGP announcements

All AGP announcements

Source: AGP Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.